My kid that's a medical professional sent me this…sent to providers…
Key takeaways:
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine soon after starting immune checkpoint inhibitors survived nearly twice as long.
A randomized phase 3 trial is planned.
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value in personalized vaccines.
The prevailing theory has been that a therapy tailored to each patient’s unique genomic profile — and designed to instruct the body to activate an immune response to cancer-specific proteins — offers the greatest chance for success.
Consequently, the discovery that a widely available mRNA vaccine with no direct relevance to a person’s tumor or mutational pattern may help train the immune system to eliminate cancer has the potential to “turn the field on its head,” Elias Sayour, MD, PhD, a pediatric oncologist at University of Florida, told Healio.
https://www.healio.com/news/hematology-oncology/20251103/potential-new-paradigm-covid19-mrna-vaccines-boost-response-to-cancer-immunotherapy?utm_source=selligent&utm_medium=email&utm_campaign=20251105HM&utm_content=20251105HM